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Background: Mother-to-child transmission of human immune deficiency virus (HIV) is the most common route of
HIV transmission in the pediatric age group. A number of risk factors contribute to the rate of this transmission.
Such risk factors include advance maternal HIV disease, lack of anti-viral prophylaxis in the mother and child, mixing
of maternal and infant blood during delivery and breastfeeding. This study aims to determine the cumulative HIV
infection rate by 18 months and the associated risk factors at the University of Nigeria Teaching Hospital, Enugu.
Results: A retrospective study, involving HIV exposed infants seen at the pediatric HIV clinic of UNTH between
March 2006 and September 2008. Relevant data were retrieved from their medical records. The overall rate of
mother to child transmission of HIV in this study was 3.9% (95% CI 1.1%- 6.7%). However, in children breastfed for
3 months or less, the rate of transmission was 10% (95% CI −2.5%-22.5%), compared to 3.5% (95% CI 0.5%-6.5%) in
children that had exclusive replacement feeding.
Conclusions: This retrospective observational study shows a 3.9% cumulative rate of mother-to-child transmission
of HIV by 18 months of age in Enugu. Holistic but cost effective preventive interventions help in reducing the rate
of mother-to-child transmission of HIV even in economically-developing settings like Nigeria.
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The first documented case of Acquired Immune Defi-
ciency Syndrome (AIDS) in Nigeria was in 1986 in a
13 year old child in Calabar, Cross River State [1]. Since
then, children have continued to remain vulnerable to
this epidemic in Nigeria. Children can be infected with
the virus through mother-to-child transmission (MTCT),
blood transfusion, unprotected sex and through the use
of non-sterile sharp objects [1,2]. MTCT is the most
common route and is responsible for as much as 70 to* Correspondence: zionagoz@yahoo.co.uk
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reproduction in any medium, provided the or95% [3-6] of the infection in the pediatric age group. The
next most common route of HIV transmission in chil-
dren living in economically-developing countries is blood
transfusion.[7,8]. This route accounts for about 5 to 20%
of pediatric AIDS [3,4].
MTCT can occur in utero, during labor and delivery,
and postnatally through breastfeeding. A number of risk
factors for MTCT of HIV have been documented. The
risk factors associated with transmission during labor
are prolonged rupture of uterine membrane for more
than 4 hours, prolonged labor, mixing of maternal and
fetal blood which happens more with tears and episioto-
mies [5,9]. The risk factors associated with transmission
post-natally are breastfeeding and mixed feeding [5,9].
The World Health Organization (WHO) had noted that
with successful interventions, the risk of MTCT can beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Demographic characteristics and feeding choices
for the 178 children in whom HIV infection was
ascertained by 18 months
Feeding Male Female Total HIV
infectedChoice (%) (%) (%)
BMS 80(44.9) 62 (34.9) 142 (79.8) 5
EBF (1) 11 (6.2) 9 (5.0) 20 (11.2) 2
EBF (2) 1(0.6) 1(0.6) 2 (1.1) 0
Mixed feeding 9 (5.1) 5 (2.8) 14 (7.9) 0
Total 101(56.7) 77 (43.3) 178 (100) 7
BMS=Breast Milk Substitute; EBF (1) = Exclusive Breastfeeding for 3 months or
less; EBF (2) = Exclusive Breastfeeding for 3–6 months. There was no
statistically significant difference in the risk of becoming HIV infected between
children in different categories at 95% confidence level.
Legend: The table is showing the demographic characteristics and feeding
choices for the 178 children in whom HIV-infection status was ascertained by
18 months.
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retroviral drugs (ARVs) in preventing MTCT has been
demonstrated especially during the pre-natal and intra-
partum periods [7,8]. These ARVs can be given as
prophylaxis or highly active antiretroviral therapy to the
mother and as prophylaxis to the baby.
Infant feeding in the context of HIV is still a challen-
ging issue in economically-developing countries; with
breastfeeding contributing about 30 to 50% of the
MTCT of HIV [8]. Breast milk is usually readily avail-
able, free of charge and contains protective agents such
as phagocytes, lactoferrin, oligisacharides and immuno-
globulins [11]. These protective agents help protect
against common childhood illnesses such as diarrhea
and respiratory infections [11]. Unfortunately, breast-
feeding is also a mode of HIV transmission. In
economically-developed countries like the United States
and United Kingdom, the advice from national health
agencies is usually to avoid breastfeeding altogether be-
cause the risk of HIV transmission far outweighs the
risks associated with replacement feeding [12]. . In eco-
nomically developing countries on the other hand, the
recommendation for infant feeding is less emphatic, and
initially depended on a mother's individual situation and
choice. The WHO had posited that “when replacement
feeding is acceptable, feasible, affordable, sustainable and
safe, avoidance of all breastfeeding by HIV-infected
mothers is recommended; otherwise, exclusive breast-
feeding is recommended during the first months of
life”[13]. It may not be surprising then that in Africa, be-
tween one third and one half of infant HIV infections
are due to breastfeeding [14]. Currently, WHO in its
rapid advice of 2009 recommends that HIV exposed
infants in economically developing countries should be
breast fed for up to a year with a proviso; atleast either
the baby or mother remains on antiretroviral drug(s)
[15]. This is a retrospective observational study of the
pre-Rapid Advice era at University of Nigeria Teaching
Hospital (UNTH). It is hoped that our findings will pro-
vide the basis for comparison with the rate of transmis-
sion after implementation of the new guideline on HIV
and infant feeding.
Results
A total of 227 HIV exposed babies were enrolled into the
HIV Exposed Infant Clinic and complete data retrieved
for 178 babies. The forty-nine children for whom the
data were not retrieved were lost to follow up. These
were children that did not return to the clinic after their
first visit and were not analyzed further. Out of the 178,
there were 101 males and 77 females with male: female
ratio of 1.3:1 as shown in Table 1. This difference in gen-
der was not statistically significant (χ2 = 3.24, p = 0.72).
Data on ante-natal history and place of delivery wereavailable in 128 subjects; 24.2% of the mothers had ante-
natal care at UNTH but delivered elsewhere, 0.4% deliv-
ered at UNTH but had ANC elsewhere, 40.6% had both
ANC and delivery at UNTH while 31.3% had neither
ANC nor delivery at UNTH. There was a statistically sig-
nificant differences in the rate of HIV transmission be-
tween the children depending on places of ANC and
delivery (χ2 = 37.31, p< 0.05). The average birth weight
of all babies seen was 3.2 ± 0.6 kg. The average weight at
3 and 6 months respectively for the infected children and
those that had mixed feeding were lower compared to
those that received breast milk substitutes or exclusive
breastfeeding as depicted in Figure 1. However, a Kruskal
Wallis test on one way ANOVA showed no statistically
significant difference amongst the three modes of feeding
in respect to the average weights of the children.
Concerning the 178 babies whose data were retrieved,
the partners of 82 (46.1%) mothers were also HIV sero-
positive, 64 (36%) had discordant results with their
partners (sero-negative spouses) while the sero-status of
the partners of 32 (18%) women were not recorded. Most
of the women (82.6%) received anti-retroviral drugs dur-
ing the index pregnancy. Delivery of the babies was
through the vaginal route in 87.1% of the mothers, cae-
sarean operation in 12.4% while the mode of delivery
could not be ascertained in one woman. None of the cae-
sarean deliveries was performed to prevent MTCT of
HIV. Indications for caesarean operations varied from
poor progress of labor to previous scars. Majority (82.6%)
of the infants received single dose nevirapine (SdNVP) at
birth that was followed with daily Ziduvudine for 6 weeks.
The rest received Zidovudine only (7.9%), SdNVP only
(1.1%) and no anti-retroviral prophylaxis in 8.4% of the
children. All the anti-retroviral medications were pre-
scribed at UNTH Enugu.
The Infant feeding options available at UNTH Enugu
for HIV positive mothers were exclusive breast feeding
Figure 1 This bar plot shows the average infant weight data for the 171 uninfected and 7 infected children with error bars (from the
minimum to the maximum value) at birth, 3rd and 6th month grouped into the feeding choices made.
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ment feeding using breast milk substitutes. One hundred
and forty-two babies (79.8%) were on exclusive breast
milk substitute for 3 months, 22 (12.3%) received only
breast milk for less than 6 months while 14 (7.9%) had
mixed feeding (breast feeding and breast milk substitute)
as shown in Table 1. None of the mothers breastfed for
more than 6 months. Seven of the babies in this study
were confirmed HIV positive while 171 were negative,
giving an overall MTCT of HIV rate of 3.9% (95% CI
1.1%- 6.7%). Of the 7 infected babies, 3 were males and
4 females. Except for one, all the mothers of the HIV
positive infants received antiretroviral medications dur-
ing pregnancy at UNTH Enugu. Assessment of the
mothers’ adherence to the ARVs was by verbal question-
ing. There was no statistically significant difference in
infants’ HIV sero-status with respect to anti-retroviral
medications among the mothers during pregnancy
(χ2 = 0. 824, p = 0.05). All of the 7 fathers of these HIV
positive babies were also HIV sero-positive. Six of the 7
HIV positive babies were delivered via the vaginal route
compared to one by caesarean section. There was no
statistically significant difference between the two routes
of delivery and Infants’ HIV status (χ2 = 0. 968, p = 0.64).
None of the 7 HIV infected babies was delivered at
UNTH; one was actually delivered at home by a trad-
itional birth attendant.In terms of infants’ post exposure prophylaxis, 6
infants (4.1%) among those that received both single
dose nevirapine and 6 weeks of zidovudine became
HIV infected compared to only child (6.7%) from the
group that received no post exposure prophylaxis. This
difference was not statistically significant (χ2 = 0.96,
p = 0.811).
Among babies that had exclusive replacement feeding,
3.5% (95% CI 0.5%-6.5%) became HIV positive compared
to 10% (95% CI −2.5%-22.5%) among those that had ex-
clusive breast feeding for 3 months or less. Interestingly,
none of the babies that were breastfed exclusively for
more than 3 months or had mixed feeding tested HIV
positive. However, there was no statistically significant
difference between the various modes of infant feeding
and infant’s HIV sero-positivity (χ2 = 2.67, p = 0.446).
Discussion
Eighteen percent of the children were lost to follow up.
They did not return to the clinic after the initial enrol-
ment and we are not sure what happened to them since
our program does not have any mechanism in place for
tracking defaulters. The cumulative mother-to-child HIV
transmission rate in this study was 3.9% (95% CI 1.1%-
6.7%). In the absence of any efficacious intervention to
prevent transmission, the risk of mother-to-child trans-
mission of HIV is approximately 15 to 42% [16]. In
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of HIV has been reduced to 1% as a result of the use of
Pediatric AIDS Clinical Trials Group study (PACTG 076)
regimen, highly active anti-retroviral therapy (HAART),
appropriate management of labor and delivery; and
avoidance of breastfeeding [17]. In a UK study, the rate
of MTCT of HIV was 2% [18], comparable to less than
2% reported from clinical trials in other developed coun-
tries [19]. The UK study further noted that 70.6% of their
subjects received HAART consisting of 3 or more drugs
[18].
In economically-developing countries, the mother-to-
child HIV transmission rate varies in the various litera-
tures depending on the available interventions in place in
a particular setting. In Abidjan, Cote d’Ivoire for instance,
the cumulative rate of mother-to-child transmission of
HIV was ascertained among 250 mother-baby pairs seen
between August 2003 and June 2005 [19]. The HIV
exposed infants in their study received post exposure
prophylaxis and were followed up till their HIV status
could be determined. The mothers were divided into two
cohorts of those that received HAART (143) and those
that had only short course anti-retroviral prophylactic
regimen (107). At 12 months, 5.7% (95% CI 2.5%–9.0%)
of the infants were diagnosed as HIV-infected: 3.3% (95%
CI 0.0%–6.9%) in the HAART group and 7.5% (95% CI
2.8%–12.3%) in the short course ARV for PMTCT group.
This cumulative transmission rate of 5.7% is slightly
higher than the 3.9% (95% CI 1.1%- 6.7%) cumulative rate
documented in this study. This can partly be explained
by the fact that all the mothers in this current study
received HAART compared to only a proportion from
the Abidjan study. In fact, among those that received
HAART in the Abidjan study, only 3.3% transmission
rate was recorded and this was comparable to the 3.9%
documented in the current study. Although the WHO
recommends that HAART be given to HIV positive
women who need it for their own health in economically-
developing countries, several studies have demonstrated
the superiority of HAART over short course anti-
retroviral regimens in preventing mother-to-child trans-
mission of HIV [20-22]. In the landmark, Pediatric AIDS
Clinical Trials Group Protocol 076 Study (PACTG 076),
8.3% in the zidovudine group and 25.5% in the placebo
group were HIV infected [21]. The 8.3% HIV transmis-
sion rate in the zidovudine group of the PACTG 076
study group differs from the 3.9% documented in this
current study [21]. The lower transmission rate in this
study may once again highlight the superiority of
HAART over monotherapy in reducing rate of peri-natal
HIV transmission. In a South African study, the overall
rate of MTCT among women receiving HAART was
4.9% [22]. This rate was however lower among the chil-
dren of women that became pregnant on HAART (0.7%)compared to those who initiated HAART during preg-
nancy (5.7%) [22].
This cumulative transmission rate of 3.9% in this study
very sharply contrasts with another study by Mukhtar-
Yola et al. [23] at Kano, North-east Nigeria. Their obser-
vational study was also retrospective in nature involving
two groups of mother-baby pairs (PMTCT and non
PMTCT groups). They found that as high as 25% trans-
mission rate among the PMTCT group and even higher
(53.7%) among the non PMTCT group. This may not be
surprising as only 18.1% of the mothers in their PMTCT
group were on HAART and there was a higher rate of
mixed feeding compared with only 7.9% rate of mixed
feeding in this study.
Mode of delivery, choice of post exposure prophylactic
ARVs for the infants, and infant feeding choice did not
have a statistically significant influence on the transmis-
sion rate of HIV in this study. Interestingly too, infant
feeding choices was not a statistically significant predic-
tors of transmission rate in the Abidjan study [19]. How-
ever, the influence of these variables (mode delivery,
infant’s ARV prophylaxis and feeding choice) have to be
cautiously interpreted in this study as the majority of the
babies were delivered per vaginal (87.1%), had SdNVP
plus 6 weeks Zidovudine (82.6%) and were on exclusive
breast milk substitute for 6 weeks (79.8%). This leaves
very few controls to draw reasonable conclusions from
these variables. Curiously, all the 7 infected babies were
delivered outside UNTH. This may be due to the fact
that delivery practices at such places are suboptimal and
re-inforces the need to train health workers in best prac-
tices. This calls for further scrutiny of the role of place
of delivery in the transmission of HIV infection espe-
cially with respect to safe blood handling and use of ster-
ilized instruments.
Only 2 out of the 7 infections in this study were
recorded among the infants that had some form of
breast feeding. This can be explained by the fact that
most of the babies (79.8%) in this study received exclu-
sive formula feeding [provided as support by the Gov-
ernment of Nigeria (GoN)] while only 7.9% had mixed
feeding. This underscores the importance of exclusive
formula feeding in reducing MTCT of HIV. While being
associated with reduced HIV transmission in exposed
infants, exclusive formula feeding in developing coun-
tries is still at huge costs though. These include procur-
ing infant formula, increased rate of common childhood
illnesses like diarrhea, respiratory illnesses as well as
increased mortality. We therefore, theorise that the bulk
of the HIV infections in this study may have happened
“in utero” or during delivery. While all the 128 women
for whom ante-natal history data were available received
HAART, there is the possibility of non-adherence to the
anti-retroviral medications during pregnancy by some of
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ease, opportunistic infections and severe immune-
suppression. These variables were not explored in this
review. Additionally, the details of labor and delivery in-
cluding known risk factors such as prolonged rupture of
membrane, episiotomies and instrumental deliveries
were not documented in this review.
Conclusions
This retrospective observational study shows a cumula-
tive 3.9% rate of MTCT of HIV by 18 months of age in
Enugu. This may be attributed to a well-established
multi-disciplinary team approach between the Obstetric
and Pediatric Departments of UNTH Enugu in running
the PMTCT program. Commencing infant feeding coun-
selling during the ANC and reinforcing that throughout
the duration of ANC and exposed infant follow up may
have helped keep the rate of mixed feeding low. Only 7
children were positive, therefore this study lacks statis-
tical power to evaluate the role of risk factors such as
maternal HIV disease, ARV prophylaxis, mode of deliv-
ery and infant feeding. We therefore, recommend a pro-
spective study to evaluate the role of these risk factors in
the MTCT of HIV.
Methods
Study population
The HIV exposed infants’ clinic was established at Uni-
versity of Nigeria Teaching Hospital, Enugu in March
2006. It is a weekly clinic created to cater for the specific
health needs of HIV exposed children and provide close
monitoring that ensures prompt referral of HIV infected
children for treatment. The Pediatric HIV clinic is being
supported by the AIDS Prevention In Nigeria-Harvard
University project through the United States Presidential
Emergency Fund for AIDS Relief (PEPFAR). It has a
strong linkage with the Obstetrics unit of the hospital
which ensures timely referral of all exposed infants deliv-
ered in the hospital to the clinic. All HIV positive women
seen at UNTH, Enugu are placed on anti-retroviral drugs
according to the national guidelines. Such women are
provided with infant feeding counselling during HIV
post-test counselling. Infant feeding counselling is rein-
forced throughout the Ante Natal Care (ANC) and
exposed infant follow up clinic. The infant feeding
choices available at the time were exclusive breastfeeding
for short duration (3-6 months) or exclusive replacement
feeding using breast milk substitutes. Complementary
feeding is then started comprising mainly of local pap
gruel made from corn, variedly fortified with soya beans,
infant formula, ground paste, crayfish and other locally-
available products. The HIV Exposed clinic also receives
referrals from health facilities within and outside Enugu
metropolis. The babies are started on 2 mg/kg of SdNVPwithin 72 hours as applicable, then daily 4 mg/kg of sus-
pension Zidovudine for 6 weeks. Cotrimoxazole is started
at 6 weeks. The children are followed up every two weeks
for the first 6 weeks and then monthly till they attain the
age of 18 months. Growth is monitored and infant feeding
counselling is provided at each visit. The immunization
status is also checked.
Antibody testing alone was used to test for HIV in-
fection in 48 children at 18 months of age who were
followed up and discharged before DNA PCR became
available. None of these 48 children was breastfed be-
yond 6 months of age. With the availability of DNA
PCR in March 2008, all our remaining clients below
18 months were offered DNA PCR and antibody test-
ing subsequently at 18 months. For babies that were
breastfed, repeat DNA PCR was done 6 weeks after
cessation of breastfeeding. There was no discordance
between the DNA PCR results and the subsequent
antibody test results that was done at 18 months. Al-
though DNA PCR is now offered routinely at six
weeks, the exposed babies are still followed up irre-
spective of the DNA PCR result till they are 18 months
when antibody testing is also offered.Data collection
This was a retrospective study. The case notes/records
of all enrolled HIV exposed infants attending the clinic
within a 30 month period from March 2006 to Sept
2008 were critically reviewed. Data extracted included
gender, birth weight, use of pre delivery ARV in the
mother, mode of delivery, infant feeding option; DNA
PCR results where available and antibody test result at
18 months of age.Data analysis
Retrieved data were validated and analyzed using the
Statistical Package for Social Sciences (SPSS) version
19.0 [24]. Each risk factor was tested for statistical asso-
ciation with the risks of HIV infection by 18 months of
age. Chi-squared test was used to test for significant as-
sociation of categorical variables. Graph Pad Prism ver-
sion 5.04 [25]. (2010) was used to construct the bar plot
with error lines for the different feeding choices. A one
way Analysis of Variance (ANOVA) was used to test for
significant association of the average weights of the
infants with various modes of infant feeding.
The level of statistical significance used was 0.05 and
95% confidence interval reported.Ethical consideration
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